As of 2026-01-27, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 17.7x | 17.6x |
| Forward P/E multiples | 14.9x - 16.6x | 16.6x |
| Fair Price | (10.54) - (11.02) | (11.20) |
| Upside | -169.1% - -172.3% | -173.4% |
| Date | EV/EBITDA |